GenMark Diagnostics Inc (GNMK) - Product Pipeline Analysis, 2017 Update

Date: May 18, 2017
Pages: 36
Price:
US$ 750.00 US$ 675.00
Offer valid until September 1, 2017!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GA66FABC0FEEN
Leaflet:

Download PDF Leaflet

GenMark Diagnostics Inc (GNMK) - Product Pipeline Analysis, 2017 Update
Summary

GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis. The company offers educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company GenMark Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
GenMark Diagnostics Inc Company Overview
GenMark Diagnostics Inc Company Snapshot
GenMark Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
GenMark Diagnostics Inc – Pipeline Analysis Overview
GenMark Diagnostics Inc - Key Facts
GenMark Diagnostics Inc - Major Products and Services
GenMark Diagnostics Inc Pipeline Products by Development Stage
GenMark Diagnostics Inc Pipeline Products Overview
2D6 Tamoxifen Metabolism Test
2D6 Tamoxifen Metabolism Test Product Overview
ePlex Blood Culture Identification Fungal Pathogen Panel
ePlex Blood Culture Identification Fungal Pathogen Panel Product Overview
ePlex Blood Culture Identification Gram-Negative Panel
ePlex Blood Culture Identification Gram-Negative Panel Product Overview
ePlex Blood Culture Identification Gram-Positive Panel
ePlex Blood Culture Identification Gram-Positive Panel Product Overview
ePlex Central Nervous System Panel
ePlex Central Nervous System Panel Product Overview
ePlex Gastrointestinal Pathogen Panel
ePlex Gastrointestinal Pathogen Panel Product Overview
ePlex HCV Genotyping Panel
ePlex HCV Genotyping Panel Product Overview
ePlex Respiratory Pathogen Panel
ePlex Respiratory Pathogen Panel Product Overview
ePlex System
ePlex System Product Overview
eSensor 2C19 Genotyping Test
eSensor 2C19 Genotyping Test Product Overview
eSensor 3A4/3A5 Genotyping Test
eSensor 3A4/3A5 Genotyping Test Product Overview
eSensor KRAS Test
eSensor KRAS Test Product Overview
Fully Integrated In-Vitro Diagnostic Platform
Fully Integrated In-Vitro Diagnostic Platform Product Overview
GenMark Diagnostics Inc - Key Competitors
GenMark Diagnostics Inc - Key Employees
GenMark Diagnostics Inc - Locations And Subsidiaries
Head Office
Recent Developments
GenMark Diagnostics Inc, Recent Developments
Apr 20, 2017: GenMark Achieves CE Mark For Its ePlex Blood Culture Identification Fungal Pathogen Panel
Feb 28, 2017: GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results
Jan 10, 2017: GenMark Announces Preliminary Q4 2016 Financial Results
Dec 22, 2016: GenMark Diagnostics Submits 510(k) Applications to the FDA for ePlex Sample-to-Answer Instrument and Respiratory Pathogen Panel
Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results
Jul 28, 2016: GenMark Diagnostics Reports Q2 Financial Results
Jun 08, 2016: GenMark Achieves CE Mark for its ePlex Respiratory Pathogen Panel
Jun 08, 2016: GenMark Achieves CE Mark For Its ePlex Instrument System
May 03, 2016: GenMark Reports First Quarter 2016 Results
Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GenMark Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
GenMark Diagnostics Inc Pipeline Products by Equipment Type
GenMark Diagnostics Inc Pipeline Products by Indication
GenMark Diagnostics Inc, Key Facts
GenMark Diagnostics Inc, Major Products and Services
GenMark Diagnostics Inc Number of Pipeline Products by Development Stage
GenMark Diagnostics Inc Pipeline Products Summary by Development Stage
2D6 Tamoxifen Metabolism Test - Product Status
2D6 Tamoxifen Metabolism Test - Product Description
ePlex Blood Culture Identification Fungal Pathogen Panel - Product Status
ePlex Blood Culture Identification Fungal Pathogen Panel - Product Description
ePlex Blood Culture Identification Gram-Negative Panel - Product Status
ePlex Blood Culture Identification Gram-Negative Panel - Product Description
ePlex Blood Culture Identification Gram-Positive Panel - Product Status
ePlex Blood Culture Identification Gram-Positive Panel - Product Description
ePlex Central Nervous System Panel - Product Status
ePlex Central Nervous System Panel - Product Description
ePlex Gastrointestinal Pathogen Panel - Product Status
ePlex Gastrointestinal Pathogen Panel - Product Description
ePlex HCV Genotyping Panel - Product Status
ePlex HCV Genotyping Panel - Product Description
ePlex Respiratory Pathogen Panel - Product Status
ePlex Respiratory Pathogen Panel - Product Description
ePlex System - Product Status
ePlex System - Product Description
eSensor 2C19 Genotyping Test - Product Status
eSensor 2C19 Genotyping Test - Product Description
eSensor 3A4/3A5 Genotyping Test - Product Status
eSensor 3A4/3A5 Genotyping Test - Product Description
eSensor KRAS Test - Product Status
eSensor KRAS Test - Product Description
Fully Integrated In-Vitro Diagnostic Platform - Product Status
Fully Integrated In-Vitro Diagnostic Platform - Product Description
GenMark Diagnostics Inc, Key Employees
Glossary

LIST OF FIGURES

GenMark Diagnostics Inc Pipeline Products by Equipment Type
GenMark Diagnostics Inc Pipeline Products by Development Stage

COMPANIES MENTIONED

Nanosphere Inc
Luminex Corp
Illumina, Inc.
Epinex Diagnostics Inc
Cepheid
Skip to top


Ask Your Question

GenMark Diagnostics Inc (GNMK) - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: